default image

Urologie

Information and services of the department

  • Number of inpatient cases: 74

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 25
Hyperplasia of prostate (N40) 16
Other disorders of urinary system - Stress incontinence female male (N39.3) 4
Malignant neoplasm of prostate (C61) not specified
Malignant neoplasm of testis (C62.1) not specified
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) not specified
Malignant neoplasm of bladder - Malignant neoplasm of anterior wall of bladder (C67.3) not specified
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) not specified
Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) not specified
Other disorders of peritoneum (K66.2) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 52
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 21
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 20
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 13
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 12
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 12
Use of an imaging procedure during an operation (3-992) 6
(9-984.7) 5
Operation to lift the neck of the bladder in cases of urinary incontinence, with access through the vagina (5-593.20) 4
Taking a tissue sample (biopsy) of the testis through a surgical incision (1-565) 0

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Number Group
54 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at colleges and universities
Doctoral supervision
No. Training in other healing professions Comment
HB03 Physical therapist / physiotherapist (m/f)
HB01 Nurse and health care worker (m/f)

Brigitte Kalbe

Patientenbeauftragte

Phone: 05321 -441640-0
Mail: moc.soipelksa@eblak.b

Brigitte Kalbe

Patientenbeauftragte

Phone: 05321 -441640-0
Mail: moc.soipelksa@eblak.b

Madeleine Rakel-Sonderfeld

Beschwerdemanagement

Phone: 05321 -44-1706
Mail: moc.soipelksa@lekar.m

Monika Karsten

Qualitätskoordinatorin

Phone: 05321 -441677-
Mail: moc.soipelksa@netsrak.m

Prof. Dr. Jörn Heine

Vorsitzender Hygienekommission / Ärztlicher Direktor

Phone: 05321 -44-1302
Mail: moc.soipelksa@nielk.os

Prof. Dr. Jörn Heine

Chefarzt Klinik für Anästhesie- und Intensivmedizin, Ärztlicher Direktor

Phone: 05321 -441302-
Mail: moc.soipelksa@enieh.j